No Record Found
Sector
PharmaceuticalsOpen
₹664.9Prev. Close
₹662.25Turnover(Lac.)
₹833.87Day's High
₹680Day's Low
₹65152 Week's High
₹84252 Week's Low
₹511.4Book Value
₹128.99Face Value
₹2Mkt Cap (₹ Cr.)
5,296.17P/E
29.62EPS
22.13Divi. Yield
0.1513 Sep 2024
12:00 AM
AGM
Announcement Date: 13 Sep, 2024
6 Aug 2025
12:00 AM
Board Meeting
Agenda : Audited Result
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 16.1 | 16.1 | 16.1 | 14.64 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 799.27 | 683.36 | 599.59 | 253.95 |
Net Worth | 815.37 | 699.46 | 615.69 | 268.59 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 |
|---|---|
Revenue | 385.36 |
yoy growth (%) | |
Raw materials | -128.12 |
As % of sales | 33.24 |
Employee costs | -32.76 |
| Y/e 31 Mar( In .Cr) | Mar-2021 |
|---|---|
Profit before tax | 167.31 |
Depreciation | -6.76 |
Tax paid | -43.71 |
Working capital | |
Other operating items |
| Y/e 31 Mar | Mar-2021 |
|---|---|
Growth matrix (%) | |
Revenue growth | |
Op profit growth | |
EBIT growth | |
Net profit growth |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,600.3 | 77.09 | 3,84,001.57 | 753.53 | 1 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,190.5 | 70.34 | 1,64,334.34 | 557 | 0.48 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,579.8 | 24.7 | 1,27,613.03 | 1,303.13 | 1.01 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,604.8 | 61.33 | 1,21,917.8 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,263.2 | 15.29 | 1,05,437.41 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman & WTD
Satish Waman Wagh
Whole-time Director
Smita Satish Wagh
Whole-time Director
Soloni Satish Wagh
Joint Managing Director
Shivani Satish Wagh
Whole-time Director
Balasahab Gulabrao Sawant
Independent Director
Dileep Kumar Jain
Independent Director
Dinesh N Modi
Independent Director
Neelam Yashpal Arora
Whole-time Director
Manoj Deo Dorlikar
Independent Director
Ganapati D Yadav
Independent Director
Sunil Subhash Bhagwat
Company Sec. & Compli. Officer
Prachi Sathe
207/208 Udyog Bhavan,
Sonawala Road Goregaon (East),
Maharashtra - 400063
Tel: 91-22-40332727
Website: http://www.supriyalifescience.com
Email: cs@supriyalifescience.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Supriya Lifescience Limited was initially constituted on October 29, 1985, as a Partnership Firm under the name M/s Supriya Chemicals. The Partnership Firm was last re-constituted pursuant to a Partne...
Read More
Reports by Supriya Lifescience Ltd
What is the Supriya Lifescience Ltd share price today?
What is the Market Cap of Supriya Lifescience Ltd?
What is the PE and PB ratio of Supriya Lifescience Ltd?
What is the 52 Week High and Low of Supriya Lifescience Ltd?
What is the CAGR of Supriya Lifescience Ltd?
What is the shareholding pattern of Supriya Lifescience Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.